Cargando…

Human Polyomavirus JCPyV and Its Role in Progressive Multifocal Leukoencephalopathy and Oncogenesis

The human neurotropic virus JCPyV, a member of the Polyomaviridiae family, is the opportunistic infectious agent of Progressive Multifocal Leukoencephalopathy (PML), a fatal disease seen in severe immunosuppressive conditions and, during the last decade, in patients undergoing immunotherapy. JCPyV i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Del Valle, Luis, Piña-Oviedo, Sergio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694743/ https://www.ncbi.nlm.nih.gov/pubmed/31440465 http://dx.doi.org/10.3389/fonc.2019.00711

Ejemplares similares

JCPyV T-Antigen Activation of the Anti-Apoptotic Survivin Promoter—Its Role in the Development of Progressive Multifocal Leukoencephalopathy
por: Del Valle, Luis, et al.
Publicado: (2020)

JCPyV VP1 Mutations in Progressive Multifocal Leukoencephalopathy: Altering Tropism or Mediating Immune Evasion?
por: Lauver, Matthew D., et al.
Publicado: (2020)

Co-Detection of EBV and Human Polyomavirus JCPyV in a Case of AIDS-Related Multifocal Primary Central Nervous System Diffuse Large B-Cell Lymphoma
por: Barbier, Mallory T., et al.
Publicado: (2023)

Polyomavirus JCPyV infrequently detectable in adenoid cystic carcinoma of the oral cavity and the airways
por: Hämetoja, Hanna, et al.
Publicado: (2019)

Specific and quantitative detection of Human polyomaviruses BKPyV and JCPyV in the healthy Pakistani population
por: Hussain, Iqra, et al.
Publicado: (2017)

The differential presence of human polyomaviruses, JCPyV and BKPyV, in prostate cancer and benign prostate hypertrophy tissues
por: Shen, Chenghuang, et al.
Publicado: (2021)

Human polyomavirus BKPyV and JCPyV serostatus has no impact on women´s human papillomavirus infection outcome
por: Laine, Hanna K., et al.
Publicado: (2023)

Induction of Brain Tumors by the Archetype Strain of Human Neurotropic JCPyV in a Transgenic Mouse Model
por: Del Valle, Luis, et al.
Publicado: (2021)

Discriminating between JCPyV and BKPyV in Urinary Virome Data Sets
por: Mormando, Rita, et al.
Publicado: (2021)

JCPyV-Induced MAPK Signaling Activates Transcription Factors during Infection
por: DuShane, Jeanne K., et al.
Publicado: (2019)

Detection of human neurotropic JCPyV DNA sequence in pediatric anaplastic xanthoastrocytoma
por: Passerini, Sara, et al.
Publicado: (2023)

The MAPK/ERK Pathway and the Role of DUSP1 in JCPyV Infection of Primary Astrocytes
por: Wilczek, Michael P., et al.
Publicado: (2021)

Teriflunomide Inhibits JCPyV Infection and Spread in Glial Cells and Choroid Plexus Epithelial Cells
por: O’Hara, Bethany A., et al.
Publicado: (2021)

Inhibition of JCPyV infection mediated by targeted viral genome editing using CRISPR/Cas9
por: Chou, Yi-ying, et al.
Publicado: (2016)

High anti-JCPyV serum titers coincide with high CSF cell counts in RRMS patients
por: Schneider-Hohendorf, Tilman, et al.
Publicado: (2020)

IFNα and β Mediated JCPyV Suppression through C/EBPβ-LIP Isoform
por: May, Dana, et al.
Publicado: (2021)

Prevalence and viral loads of polyomaviruses BKPyV, JCPyV, MCPyV, TSPyV and NJPyV and hepatitis viruses HBV, HCV and HEV in HIV-infected patients in China
por: Zhou, Xianfeng, et al.
Publicado: (2020)

JCPyV miR-J1-5p in Urine of Natalizumab-Treated Multiple Sclerosis Patients
por: Agostini, Simone, et al.
Publicado: (2021)

PI3K/AKT/mTOR Signaling Pathway Is Required for JCPyV Infection in Primary Astrocytes
por: Wilczek, Michael P., et al.
Publicado: (2021)

New Insights on Human Polyomavirus JC and Pathogenesis of Progressive Multifocal Leukoencephalopathy
por: Bellizzi, Anna, et al.
Publicado: (2013)

JCPyV NCCR analysis in PML patients with different risk factors: exploring common rearrangements as essential changes for neuropathogenesis
por: Ciardi, Maria Rosa, et al.
Publicado: (2020)

BK polyomavirus associated progressive multifocal leukoencephalopathy in a person living with HIV
por: O'Kelly, Brendan, et al.
Publicado: (2021)

Divergent Trends of Anti-JCPyV Serum Reactivity and Neutralizing Activity in Multiple Sclerosis (MS) Patients during Treatment with Natalizumab
por: Diotti, Roberta Antonia, et al.
Publicado: (2016)

JC Polyomavirus, progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome: a review
por: Harypursat, Vijay, et al.
Publicado: (2020)

JC Polyomavirus Modifies the Expression of Human microRNAs in Progressive Multifocal Leukoencephalopathy Brain
por: Honkimaa, Anni, et al.
Publicado: (2023)

Infrequent Detection of KI, WU and MC Polyomaviruses in Immunosuppressed Individuals with or without Progressive Multifocal Leukoencephalopathy
por: Dang, Xin, et al.
Publicado: (2011)

An Elusive Target: Inhibitors of JC Polyomavirus Infection and Their Development as Therapeutics for the Treatment of Progressive Multifocal Leukoencephalopathy
por: Kaiserman, Jacob, et al.
Publicado: (2023)

Progressive Multifocal Leukoencephalopathy
por: Adang, Laura, et al.
Publicado: (2015)

Progressive Multifocal Leukoencephalopathy-Associated Mutations in the JC Polyomavirus Capsid Disrupt Lactoseries Tetrasaccharide c Binding
por: Maginnis, Melissa S., et al.
Publicado: (2013)

COS-7 and SVGp12 Cellular Models to Study JCPyV Replication and MicroRNA Expression after Infection with Archetypal and Rearranged-NCCR Viral Strains
por: Prezioso, Carla, et al.
Publicado: (2022)

Treatment of progressive multifocal leukoencephalopathy
por: Castle, Daniel, et al.
Publicado: (2019)

High expression of JC polyomavirus-encoded microRNAs in progressive multifocal leukoencephalopathy tissues and its repressive role in virus replication
por: Takahashi, Kenta, et al.
Publicado: (2020)

Comparison of qPCR with ddPCR for the Quantification of JC Polyomavirus in CSF from Patients with Progressive Multifocal Leukoencephalopathy
por: Ngouth, Nyater, et al.
Publicado: (2022)

Sequencing and analysis of John Cunningham polyomavirus DNA from acquired immunodeficiency syndrome patients with progressive multifocal leukoencephalopathy
por: Hu, Cai-Qin, et al.
Publicado: (2020)

Alterations of the miR-126-3p/POU2AF1/Spi-B Axis and JCPyV Reactivation in Multiple Sclerosis Patients Receiving Natalizumab
por: Mancuso, Roberta, et al.
Publicado: (2022)

Cytology of progressive multifocal leukoencephalopathy revisited: A case report with special reference to JC polyomavirus‐infected oligodendrocytes and astrocytes
por: Doi, Mieko, et al.
Publicado: (2021)

Progressive Multifocal Leukoencephalopathy in an Immunocompetent Patient?
por: Johansen, Krisztina K., et al.
Publicado: (2013)

Progressive multifocal leukoencephalopathy in an immunocompetent patient
por: van der Kolk, Nicolien M., et al.
Publicado: (2016)

Diagnostic delay in progressive multifocal leukoencephalopathy
por: Miskin, Dhanashri P., et al.
Publicado: (2016)

Progressive multifocal leukoencephalopathy in the absence of immunosuppression
por: Zucker, Benjamin E., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_s9ki7gd54gvh00r8joj495emsi